Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
Relationship leverages Quest's sequencing and specimen collection expertise with Scipher's precision medicine technology
New Report From Quest Diagnostics Unveils Priorities for Community Health Centers
More than 1,100 Community Health Centers – also called Federally Qualified Health Centers, or FQHC – today provide affordable, comprehensive care to over 30 million children and adults across the United States.
Universal DX Announces Strategic Collaboration With Quest Diagnostics To Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
Signal-C® uses next generation sequencing (NGS) and bioinformatics to identify methylated DNA patterns and fragments shed by colorectal cancer tumors circulating in the blood stream.
Our Work Is Helping Quest Land on Some Noteworthy Lists
The recognition began earlier this year with our ninth straight appearance on FORTUNE Magazine’s 2023 "World's Most Admired Companies" list.
Quest for Health Equity 2023 Summer Intern Spotlights
The Quest for Health Equity (Q4HE) team spearheaded a summer internship program to provide hands-on, real-work experience for scholars from the American Heart Association’s (AHA) Historically Black Colleges and Universities (HBCU) and Hispanic Serving Institutions (HSI) programs.
Think Pink: Quest Supports Women’s Breast & Heart Initiative’s National Pink Day Wellness Event
As part of the National Pink Day event, WBHI–a Quest for Health Equity (Q4HE) grantee–offered no-cost mammograms by appointment and incorporated additional health screenings to offer a more comprehensive preventive care approach, including heart screenings.
Americares and Quest Diagnostics Expand Collaboration to Support Health Equity
Americares and Quest Diagnostics, with the Quest Diagnostics Foundation, are teaming up to provide no-cost diagnostic services and expanded telehealth services to free and charitable clinics across the United States to reduce health disparities in underserved communities.
Quest Diagnostics Releases 2022 Corporate Responsibility Report
Quest Diagnostics (NYSE: DGX), the leader in diagnostic information services, today released its 2022 Corporate Responsibility Report.
Q4HE Collaborates With Western University of Health Sciences To Support Biopsies Save Lives
Quest Diagnostics, through the Quest for Health Equity (Q4HE) initiative, has teamed up with Western University of Health Sciences (WesternU) to offer no-cost diagnostic testing services to support Biopsies Save Lives.
Quest Diagnostics Named a ‘Best Place To Work for Disability Inclusion’ for Sixth Consecutive Year
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2023 Disability Equality Index® (DEI) Best Places to Work for Disability Inclusion by Disability: IN.